Your session is about to expire
← Back to Search
Disinfectant
Enhanced Disinfection for Hospital Room Contamination
N/A
Recruiting
Led By Deverick Anderson, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1, day 2, day 3, day 4
Awards & highlights
Study Summary
This trial tests if using disinfectant more often can reduce germs in the environment better than usual.
Who is the study for?
This trial is for adult patients in the hospital who are on contact precautions for any reason or have a positive culture for certain infections upon room admission. They must have spent at least one night in their room and expect to stay another 48 hours.Check my eligibility
What is being tested?
The study is testing if using Sani24, a disinfectant with persistent activity for 24 hours, can reduce environmental germs more effectively than standard EPA-registered disinfectants used in routine cleaning.See study design
What are the potential side effects?
Since this trial involves environmental disinfection rather than direct patient treatment, side effects are not directly applicable to patients but may include potential respiratory or skin reactions among staff applying the product.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1, day 2, day 3, day 4
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1, day 2, day 3, day 4
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in total room contamination in study rooms on study day 2
Secondary outcome measures
Change in total room contamination
Frequency of daily disinfection by EVS or unit personnel (control arm) and study personnel (intervention arms)
Proportion of EIP positive environmental cultures
+8 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Standard EPA-registered disinfectantExperimental Treatment1 Intervention
Application of standard EPA-registered disinfectant by study team
Group II: Sani24Experimental Treatment1 Intervention
Application of a 24-hour continuously acting quaternary ammonium salt disinfectant: Sani24 (PDI Healthcare Inc.) by study team
Group III: ControlActive Control1 Intervention
Routine disinfection completed by hospital staff
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,377 Previous Clinical Trials
3,426,240 Total Patients Enrolled
1 Trials studying Disinfection
50 Patients Enrolled for Disinfection
University of North CarolinaOTHER
168 Previous Clinical Trials
1,449,404 Total Patients Enrolled
Deverick Anderson, MDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
29 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am hospitalized with special measures for COVID-19, flu, or RSV.I am under 18 years old.I am on special precautions due to a C. difficile infection.I am an adult currently admitted to a hospital room.I expect to stay in the hospital for at least 2 days.
Research Study Groups:
This trial has the following groups:- Group 1: Sani24
- Group 2: Standard EPA-registered disinfectant
- Group 3: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies left in this clinical trial?
"Per information from clinicaltrials.gov, this trial is not currently accepting any participants. This study was initially posted on February 1st 2023 and the latest update happened on February 13th 2023. However, there are still one other trials open for enrollment at present."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger